<DOC>
	<DOCNO>NCT02203682</DOCNO>
	<brief_summary>The aim study evaluate effect subantimicrobial dose doxycycline ( 50 mg/d ) , administer 12 week , patient mild Graves ' Orbitopathy ( GO ) .</brief_summary>
	<brief_title>Doxycycline Treatment Mild Graves ' Orbitopathy</brief_title>
	<detailed_description>Graves'orbitopathy autoimmune disease treat corticosteroid surgery . But often cause severe side-effects usually use treat moderate-sever sight-threatening GO . Wait see first choice patient mild GO . Subantimicrobial dose ( SD ) doxycycline display strong anti-inflammatory immunomodulatory function , independent antibiotic property . Data clinical trial demonstrate SD doxycycline effective moderating inflammation variety autoimmune disease , rheumatoid arthritis , multiple sclerosis , rosacea periodontitis . We propose test effect subantimicrobial dose doxycycline mild GO .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Disease</mesh_term>
	<mesh_term>Immune System Diseases</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Hyperthyroidism</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Genetic Diseases , Inborn</mesh_term>
	<mesh_term>Eye Diseases , Hereditary</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Clinical diagnosis Graves ' Orbitopathy Mild GO According EUGOGO statemnt , patient mild GO usually one following：mild soft tissue involvement , exophthalmos＜18mm , temporary , diplopia . Clinical activity score low 3 Being euthyroid least 1 month date inclusion No previous specific therapy GO , except local measure 1 month date inclusion Written inform consent obtain moderatesever Graves ' Orbitopathy Sightthreatening Graves ' Orbitopathy Clinical activity score ≥ 3 Pregnant female determine positive ( serum urine ) hCG test screen prior dosing , lactate female Uncontrolled diabetes hypertension History mental / psychiatric disorder Hepatic dysfunction ( Alb , AST , ALT Alkaline phosphates level must within normal range eligibility ) Renal impairment ( Urea Creatinine level must within normal range ) Doxycycline allergy intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Graves ' orbitopathy</keyword>
	<keyword>Graves´ ophthalmopathy</keyword>
	<keyword>Thyroid eye disease</keyword>
	<keyword>Thyroid-associated ophthalmopathy</keyword>
	<keyword>Doxycycline</keyword>
	<keyword>EUGOGO</keyword>
	<keyword>CAS</keyword>
</DOC>